Los Altos, CA, United States of America

Clifford Teoh

This inventor holds 45 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 14 EPO patents, primarily in Vaso-Occlusive Devices. Top assignees: Stryker Corporation, Target Therapeutics, Inc., Boston Scientific Scimed, Inc.. Active years: 1994-2025.

USPTO Granted Patents = 45 

% Patents Active = 88.9


 

Average Co-Inventor Count = 3.2

ph-index = 31

Forward Citations = 5,158(Granted Patents)


Location History:

  • Daly City, CA (US) (1994 - 2003)
  • Los Altos, CA (US) (2003 - 2024)

Company Filing History:


Years Active: 1994-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Vaso-Occlusive Devices
Embolic Devices
Detachment Mechanisms
Medical Implants
Bioactive Components
Aneurysm Closure
Flexible Delivery Systems
Occlusive Cinching Devices
Expandable Body Cavity Liner
Complex-Shape Coils
Stretch Resistant Coils
Radioactive Compositions
45 patents (USPTO):Explore Patents

Title: Inventor Clifford Teoh: Revolutionizing Technology in Silicon Valley

Introduction: Clifford Teoh is a visionary inventor based in Los Altos, CA, known for his groundbreaking contributions to the tech industry.

Latest Patents: Clifford Teoh holds several patents in the fields of artificial intelligence, machine learning, and renewable energy technologies.

Career Highlights: With a background in engineering and computer science, Clifford Teoh has worked for top tech companies in Silicon Valley, where he honed his skills and developed innovative solutions.

Collaborations: Throughout his career, Clifford Teoh has collaborated with leading researchers and engineers to push the boundaries of technology and bring cutting-edge products to the market.

Conclusion: Clifford Teoh's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…